Indegene IPO Date, Price Band, GMP, Lot Size, Review, And Details

5/5 - (2 votes)

Are you gearing up for the much-anticipated Indegene IPO? As this innovative healthcare solutions provider gears up for its public debut, potential investors like you are keen to gather every crucial detail.

Indegene IPO Date, Price Band, GMP, Lot Size, Review, And Details
Indegene IPO Date, Price Band, GMP, Lot Size, Review, And Details

This comprehensive article is your go-to resource for the Indegene IPO, covering the essential aspects such as the IPO date, price band, grey market premium (GMP), lot size, and an in-depth review.

Consider reading: Blockbuster Year For IPOs: Out Of 60 Stocks, 57 Closed Higher Than The IPO Price In 2023

Indegene IPO Details

IPO DateMay 6, 2024 to May 8, 2024
Listing Date
Face Value₹2 per share
Price Band₹430 to ₹452 per share
Indegene IPO GMP
Indegene IPO Listing Price Prediction
Lot Size33 Shares
Total Issue Size40,746,891 shares
(aggregating up to ₹1,841.76 Cr)
Fresh Issue16,814,159 shares
(aggregating up to ₹760.00 Cr)
Offer for Sale23,932,732 shares of ₹2
(aggregating up to ₹1,081.76 Cr)
Indegene IPO Details

Indegene IPO Dates

Indegene IPO opens on May 6, 2024, and closes on May 8, 2024.

IPO Open DateMonday, May 6, 2024
IPO Close DateWednesday, May 8, 2024
Basis of AllotmentThursday, May 9, 2024
Initiation of RefundsFriday, May 10, 2024
Credit of Shares to DematFriday, May 10, 2024
Listing DateMonday, May 13, 2024
Cut-off time for UPI mandate confirmation5 PM on May 8, 2024
Indegene IPO Dates

Indegene IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)133₹14,916
Retail (Max)13429₹193,908
S-HNI (Min)14462₹208,824
S-HNI (Max)672,211₹999,372
B-HNI (Min)682,244₹1,014,288
Indegene IPO Lot Size

Indegene IPO GMP

GMP DateIndegene IPO GMPIndegene IPO Listing Price Projection
03-05-2024₹240 ₹692 (53.1%)
02-05-2024₹240 ₹692 (53.1%)
01-05-2024₹242  ₹694 (53.54%)
30-04-2024₹224  ₹676 (49.56%)
29-04-2024₹169 ₹621 (37.39%)
28-04-2024₹170  ₹170 (%)
27-04-2024₹160 ₹160 (%)
Indegene IPO GMP

Indegene Limited Company Info

Indegene Limited is a company that has carved a niche for itself in the life sciences commercialization space. Established on October 16, 1998, Indegene has been at the forefront of combining healthcare domain expertise with cutting-edge technology to modernize healthcare operations.

Vision and Purpose Indegene’s vision is to enable healthcare organizations to be future-ready. The company’s purpose resonates with its inception ethos—modernizing healthcare operations through deep medical science expertise and fit-for-purpose technology.

Global Presence and Impact With over 5,000 team members worldwide and 17 offices across the globe, Indegene has made its mark as a global entity. The company prides itself on being trusted by 20 of the top 20 global pharmaceutical companies, showcasing its credibility and reach within the industry.

Services and Solutions Indegene offers a diverse range of solutions aimed at delivering a personalized, scalable, and omnichannel experience for patients and physicians. The company assists biopharmaceutical, emerging biotech, and medical device companies in developing products, bringing them to market, and enhancing their impact throughout the product lifecycle.

Innovation and Technology At the intersection of healthcare and technology, Indegene is driving data-driven digital transformation. The company is known for enabling omnichannel healthcare professional (HCP) engagement and delivering exceptional patient services. Indegene’s acquisition of Trilogy further expands its medical writing expertise, reinforcing its commitment to innovation.

Indegene Limited Financial Highlights

Indegene Limited, a leading healthcare solutions provider, has demonstrated remarkable financial performance as it prepares for its initial public offering (IPO). In the financial year ending March 31, 2023, the company reported a significant revenue increase of 39.85% compared to the previous year. This surge in revenue underscores Indegene’s robust business model and operational efficiency. Moreover, the company’s Profit After Tax (PAT) saw an even more impressive rise of 63.43%, highlighting its ability to maximize profitability amidst expansion.

Financial Highlights:

  • Assets: Demonstrating a strong balance sheet, Indegene’s assets grew from ₹596.04 crore in March 2021 to ₹2,518.15 crore by the end of December 2023. This increase not only reflects solid growth but also a strategic accumulation of resources pivotal for long-term sustainability.
  • Revenue: The company’s revenue trajectory has been on a steady climb, reaching ₹2,364.10 crore by March 2023, up from ₹996.92 crore in March 2021. This consistent increase is a testament to Indegene’s expanding market presence and its ability to attract and retain customers.
  • Profit After Tax: Indegene’s effective tax planning and operational efficiency have propelled its profits, with the latest figures standing at ₹266.10 crore, a significant leap from ₹149.41 crore two years prior.
  • Net Worth and Reserves: The net worth of the company has grown from ₹324.51 crore in March 2021 to ₹1,327.00 crore in December 2023, supported by a strong reserve pool that increased from ₹324.19 crore to ₹1,282.65 crore in the same period.
  • Borrowings: The company has managed its borrowings prudently, with total borrowings at ₹399.33 crore as of December 2023, ensuring financial stability and readiness for future investments.

These figures not only illustrate a company that is on a rapid growth path but also one that is managing its growth sustainably. As Indegene heads towards its IPO, investors and market watchers are keenly observing these positive trends, which suggest a strong market debut and potential for future growth.

Evaluating the Indegene Limited IPO: Opportunities and Risks

As Indegene Limited gears up for its Initial Public Offering (IPO), potential investors are keen to understand the pros and cons associated with this event. Here’s an analysis based on the latest information available:

Pros:

  1. Unique Market Position: Indegene is a unique player in digital-led commercialization services for the Life Science Industry, enjoying a virtual monopoly. This distinct positioning could offer a competitive edge in the market.
  2. Steady Financial Growth: The company has shown steady growth in its top and bottom lines, indicating a strong financial trajectory. This is a positive sign for investors looking for companies with a solid financial foundation.
  3. Bright Industry Prospects: The segments in which Indegene operates are poised for bright prospects ahead. The growing demand for digital-led services in life sciences suggests a favorable market environment for the company.

Cons:

  1. High Valuation: Based on FY24 annualized earnings, the issue appears fully priced. Investors might find the IPO valuation steep, which could affect the short-term investment returns.
  2. Client Concentration Risk: Indegene earns a significant portion of its revenue from a limited number of clients. While this speaks to strong client relationships, it also poses a risk if the company loses any major clients.
  3. Market Competition: Despite its unique position, Indegene operates in a competitive market with other players vying for a share of the digital healthcare space. This could challenge the company’s growth and profitability.

The Indegene Limited IPO presents a mix of opportunities and risks. The company’s unique positioning and financial growth are compelling reasons for investment. However, the high valuation and client concentration risk are factors that require careful consideration. Investors should weigh these aspects against their investment strategy and risk appetite before making a decision.

Final Thoughts on the Indigene IPO

As we wrap up our detailed exploration of the Indegene IPO, you now have a thorough understanding of the key details—from the IPO date and price band to the GMP and lot size. With this information at your fingertips, you’re better equipped to make a well-informed decision about whether to invest in this promising company.

Remember, investing in an IPO requires careful consideration of the market conditions and the company’s potential growth. We hope this article has provided you with valuable insights and clarity to help guide your investment choices. Happy investing, and may your financial endeavours be prosperous!

Similar Posts

Leave a Reply